We previously reported that NEP stabilizes PKCδ protein expression in prostate cancer cells by inhibiting neuropeptide-induced Src signaling, which in the absence of NEP results in PKCδ protein degradation (34). The gene discussed is PRKCD; the disease is prostate carcinoma.